OxyContin Alternatives Compared
OxyContin Remove OxyContin from your drug comparison | Tramadol Remove Tramadol from your drug comparison | Gabapentin Remove Gabapentin from your drug comparison |
---|
OxyContin oxycodone Remove OxyContin from your drug comparison | Tramadol Remove Tramadol from your drug comparison | Gabapentin Remove Gabapentin from your drug comparison | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OxyContin is a long-lasting form of oxycodone, a potent narcotic pain-relieving medicine that should be reserved for mainly cancer-related pain. Use is limited by its potential for addiction and side... View more |
Tramadol is a strong pain relief medicine effective for both general and nerve-related pain. Tramadol can cause dependence and use may be limited by side effects such as nausea and... View more |
Gabapentin may be used in the treatment of partial-onset seizures and nerve pain but is likely to cause dizziness or drowsiness. Gabapentin enacarbil (brand name Horizant), a prodrug of gabapentin... View more |
||||||||||||||||||||||||
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||||||||||
Ratings & Reviews |
||||||||||||||||||||||||||
Drug Class |
||||||||||||||||||||||||||
Side Effects |
||||||||||||||||||||||||||
See the full OxyContin side effects document. |
Commonly reported side effects include: pruritus, agitation, anxiety, constipation, diarrhea, hallucination, nausea, tremor, vomiting, diaphoresis. See the full tramadol side effects document. |
Commonly reported side effects include: ataxia, dizziness, drowsiness, fatigue, fever, nystagmus disorder, sedated state, viral infection. See the full gabapentin side effects document. |
||||||||||||||||||||||||
Pricing and Coupons* Prices are without insurance |
||||||||||||||||||||||||||
View all OxyContin prices and generic prices |
View all tramadol prices |
View all gabapentin prices |
||||||||||||||||||||||||
Generic Availability |
||||||||||||||||||||||||||
Yes (this medicine) |
Yes (this medicine) |
|||||||||||||||||||||||||
Dosage Form(s) Available |
||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names |
||||||||||||||||||||||||||
Other oxycodone brands include: Dazidox, Endocodone, ETH-Oxydose, Oxaydo, Oxydose, Oxyfast, Roxicodone, Xtampza ER | ConZip, Qdolo, Tramadol Hydrochloride ER, Ultram | Fanatrex, Gabarone, Gralise, Neurontin | ||||||||||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
||||||||||||||||||||||||||
5.6 hours |
5.2 hours |
6 hours |
||||||||||||||||||||||||
CSA Schedule**View glossary of terms. |
||||||||||||||||||||||||||
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category |
||||||||||||||||||||||||||
Category N
Not classified
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
||||||||||||||||||||||||
FDA Alerts |
||||||||||||||||||||||||||
Drug Interactions |
||||||||||||||||||||||||||
A total of 530 drugs are known to interact with OxyContin:
|
A total of 541 drugs are known to interact with tramadol:
|
A total of 223 drugs are known to interact with gabapentin:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Disease Interactions |
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
First Approval Date |
||||||||||||||||||||||||||
April 05, 2010 |
March 03, 1995 |
December 30, 1993 |
||||||||||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
More Information |
||||||||||||||||||||||||||
Consumer Resources |
||||||||||||||||||||||||||
Professional Resources |
||||||||||||||||||||||||||
Related Treatment Guide |
||||||||||||||||||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.